CN Patent
CN102264722A — 作为p2x7调节剂的二氢吡啶酮酰胺
Assigned to F Hoffmann La Roche AG · Expires 2011-11-30 · 14y expired
What this patent protects
式(I)化合物或其药用盐,其中m、n、p、q、R 1 、R 2 、R 3 、R 4 、R 5 和R 6 如本文所定义。还公开了制备所述化合物和使用所述化合物用于治疗与P2X 7 嘌呤能受体有关的疾病的方法。
USPTO Abstract
式(I)化合物或其药用盐,其中m、n、p、q、R 1 、R 2 、R 3 、R 4 、R 5 和R 6 如本文所定义。还公开了制备所述化合物和使用所述化合物用于治疗与P2X 7 嘌呤能受体有关的疾病的方法。
Drugs covered by this patent
- Journavx (SUZETRIGINE) · Vertex Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.